Increased risk of rejection in cyclosporine monotherapy versus combined cyclosporine-steroid immunosuppression in young kidney recipients.
作者信息
Oppenheimer F, Cofán F, Flores R, Pais B, Ochs J, Ricart M J, Vilardell J, Campistol J M, Torregrosa J V
机构信息
Renal Transplant Unit, Hospital Clínic i Provincial, Barcelona, Spain.
出版信息
Transplant Proc. 1994 Oct;26(5):2516-7.
PMID:7940773
Abstract
摘要
相似文献
1
Increased risk of rejection in cyclosporine monotherapy versus combined cyclosporine-steroid immunosuppression in young kidney recipients.
Transplant Proc. 1994 Oct;26(5):2516-7.
2
Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.极端年龄的肾移植：环孢素A消除了年龄小于或等于5岁或大于或等于55岁受者中增加的风险。
Transplant Proc. 1994 Oct;26(5):2518-21.
3
4
5
6
Cyclosporine improves results in HLA-identical sibling renal transplants.
Transplant Proc. 1994 Oct;26(5):2514-5.
7
8
Cadaveric renal transplantation with cyclosporine monotherapy.
Transplant Proc. 1994 Aug;26(4):1915-6.
9
10
Renal transplantation in older patients with double therapy with optional change to cyclosporine monotherapy: long-term results.
Transplant Proc. 1994 Oct;26(5):2511-2.
引用本文的文献
1
Corticosteroids in kidney transplant recipients. Safety issues and timing of discontinuation.肾移植受者中的皮质类固醇。安全问题及停用时机
Drug Saf. 1995 Sep;13(3):145-56. doi: 10.2165/00002018-199513030-00002.
Zotero 插件